Search Results - Vasylė, Eglė

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Changes in Left Heart Geometry, Function, and Blood Serum Biomarkers in Patients with Obstructive Sleep Apnea after Treatment with Continuous Positive Airway Pressure

    Changes in Left Heart Geometry, Function, and Blood Serum Biomarkers in Patients with Obstructive Sleep Apnea after Treatment with Continuous Positive Airway Pressure by Kondratavičienė, Laima, Tamulėnaitė, Eglė, Vasylė, Eglė, Januškevičius, Andrius, Ereminienė, Eglė, Malakauskas, Kęstutis, Žemaitis, Marius, Miliauskas, Skaidrius

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Blood Inflammatory-like and Lung Resident-like Eosinophils Affect Migration of Airway Smooth Muscle Cells and Their ECM-Related Proliferation in Asthma

    Blood Inflammatory-like and Lung Resident-like Eosinophils Affect Migration of Airway Smooth Muscle Cells and Their ECM-Related Proliferation in Asthma by Rimkunas, Airidas, Januskevicius, Andrius, Vasyle, Egle, Palacionyte, Jolita, Janulaityte, Ieva, Miliauskas, Skaidrius, Malakauskas, Kestutis

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Integrative Cross-Talk in Asthma: Unraveling the Complex Interactions Between Eosinophils, Immune, and Structural Cells in the Airway Microenvironment

    Integrative Cross-Talk in Asthma: Unraveling the Complex Interactions Between Eosinophils, Immune, and Structural Cells in the Airway Microenvironment by Januskevicius, Andrius, Vasyle, Egle, Rimkunas, Airidas, Malakauskas, Kestutis

    Published in Diagnostics (Basel)
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Clinical Remission Criteria and Serum Levels of Type 2 Inflammation Mediators during 24 Weeks of Treatment with the Anti-IL-5 Drug Mepolizumab in Patients with T2-High Severe Asthma

    Clinical Remission Criteria and Serum Levels of Type 2 Inflammation Mediators during 24 Weeks of Treatment with the Anti-IL-5 Drug Mepolizumab in Patients with T2-High Severe Asthm... by Palacionyte, Jolita, Januskevicius, Andrius, Vasyle, Egle, Rimkunas, Airidas, Miliauskas, Skaidrius, Malakauskas, Kestutis

    Published in Diagnostics (Basel)
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    IL-5 and GM-CSF, but Not IL-3, Promote the Proliferative Properties of Inflammatory-like and Lung Resident-like Eosinophils in the Blood of Asthma Patients

    IL-5 and GM-CSF, but Not IL-3, Promote the Proliferative Properties of Inflammatory-like and Lung Resident-like Eosinophils in the Blood of Asthma Patients by Palacionyte, Jolita, Januskevicius, Andrius, Vasyle, Egle, Rimkunas, Airidas, Bajoriuniene, Ieva, Miliauskas, Skaidrius, Malakauskas, Kestutis

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Novel Serum Biomarkers for Patients with Allergic Asthma Phenotype

    Novel Serum Biomarkers for Patients with Allergic Asthma Phenotype by Palacionyte, Jolita, Januskevicius, Andrius, Vasyle, Egle, Rimkunas, Airidas, Bajoriuniene, Ieva, Vitkauskiene, Astra, Miliauskas, Skaidrius, Malakauskas, Kestutis

    Published in Biomedicines
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: